1998
DOI: 10.1111/j.1467-2995.1998.tb00169.x
|View full text |Cite
|
Sign up to set email alerts
|

Antagonism of detomidine sedation with atipamezole in horses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
19
0

Year Published

2001
2001
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(20 citation statements)
references
References 13 publications
1
19
0
Order By: Relevance
“…In wild animal capture studies involving α-2 adrenergic sedatives, atipamezole has been successfully employed to accelerate animal recovery and reduce the costs of anaesthesia monitoring (Matthews et al 1995;Ramseyer et al 1998;Hubbell and Muir 2006). However, timing of atipamezole administration is important irrespective of whether an α-2-antagonist is the only drug administered or if it is combined with other sedatives or anaesthetics.…”
Section: Discussionmentioning
confidence: 99%
“…In wild animal capture studies involving α-2 adrenergic sedatives, atipamezole has been successfully employed to accelerate animal recovery and reduce the costs of anaesthesia monitoring (Matthews et al 1995;Ramseyer et al 1998;Hubbell and Muir 2006). However, timing of atipamezole administration is important irrespective of whether an α-2-antagonist is the only drug administered or if it is combined with other sedatives or anaesthetics.…”
Section: Discussionmentioning
confidence: 99%
“…; Ramseyer et al. ; Hubbell & Muir ). MK‐467 is an α 2 ‐adrenoceptor antagonist with poor penetration of the blood–brain barrier and it therefore selectively targets peripherally located α 2 ‐adrenoceptors (Clineschmidt et al.…”
Section: Introductionmentioning
confidence: 99%
“…The a 2 -adrenoceptor antagonist atipamezole has been shown to reverse the cardiovascular effects of a 2 -adrenoceptor agonists in horses in vivo (Raekallio et al 1990;Kamerling et al 1991). As atipamezole readily enters the brain, it also at least reverses partially the desired sedative and analgesic effects of detomidine on the central nervous system (Kamerling et al 1991;Ramseyer et al 1998;Hubbell & Muir 2006). MK-467 is an a 2 -adrenoceptor antagonist with poor penetration of the blood-brain barrier and it therefore selectively targets peripherally located a 2 -adrenoceptors (Clineschmidt et al 1988).…”
Section: Introductionmentioning
confidence: 99%
“…In wild animal capture studies involving α-2 adrenergic sedatives, atipamezole has been successfully employed to accelerate animal recovery and reduce the costs of anaesthesia monitoring (Matthews et al 1995;Ramseyer et al 1998;Hubbell and Muir 2006).…”
Section: Discussionmentioning
confidence: 99%